Laboratory diagnosis of primary immunodeficiencies

Clinical Reviews in Allergy and Immunology

Volumn 46, Issue 2, 2014, Pages 154-168

  Locke, Bradley A ^a   Dasu, Trivikram ^a   Verbsky, James W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diagnosis; Flow cytometry; Laboratory assessment; Primary immunodeficiency

Indexed keywords

BRUTON TYROSINE KINASE; CD27 ANTIGEN; CD38 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; MYELOPEROXIDASE; STAT PROTEIN; TRANSCRIPTION FACTOR FOXP3; VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; ATAXIA TELANGIECTASIA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BACTERIAL INFECTION; BARE LYMPHOCYTE SYNDROME; BLOOD CELL COUNT; CELLULAR IMMUNITY; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DIGEORGE SYNDROME; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENETIC SCREENING; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GRANULOMATOSIS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMORAL IMMUNITY; HYPER IGE SYNDROME; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS DIARRHEA; INNATE IMMUNITY; INTRACELLULAR SIGNALING; IPEX SYNDROME; LABORATORY DIAGNOSIS; LEUKOCYTE ADHESION DEFICIENCY; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MYELOPEROXIDASE DEFICIENCY; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEUTROPHIL; OMENN SYNDROME; POLYENDOCRINOPATHY; PROTEIN EXPRESSION; RECURRENT INFECTION; RESPIRATORY BURST; SEVERE COMBINED IMMUNODEFICIENCY; STREPTOCOCCUS PNEUMONIAE; TH17 CELL; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

ANIMALS; CELL SEPARATION; CLINICAL LABORATORY TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STATISTICS AS TOPIC; T-LYMPHOCYTES;

EID: 84896543266     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8412-4     Document Type: Article

References (115)

1. Chapel H (2012) Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) Expert Committee on Primary Immunodeficiency 2011. Clin Exp Immunol 168:58-59
2. Fried AJ, Bonilla FA (2009) Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 22:396-414
3. Conley ME, Dobbs AK et al (2009) Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 27:199-227
4. Chase NM, Verbsky JW et al (2012) Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 33:30-9
5. Chapel H, Lucas M et al (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112:277-286
6. Murphy K, Travers P, Walport M, Janeway C (2012) Janeway's immunobiology, 8th edn. Academic, New York
7. Paris K, Sorensen RU (2007) Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 99:462-464 (Pubitemid 350086206)
8. Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N (2006) Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol 118:1336-1341 (Pubitemid 44854133)
9. Ochs HD, Davis SD, Wedgwood RJ (1971) Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases. J Clin Invest 50:2559-2568
10. Orange JS, Ballow M et al (2012) Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 130:S1-S24
11. Oliveira JB, Fleisher TA (2010) Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol 125:S297-S305
12. Cunningham-Rundles C (2001) Common variable immunodeficiency. Curr Allergy Asthma Rep 1:421-429
13. Warnatz K, Denz A et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544-1551 (Pubitemid 34533024)
14. Baumert E, Wolff-Vorbeck G, Schlesier M, Peter HH (1992) Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol 90:25-30
15. Wehr C, Kivioja T et al (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:77-85
16. Isnardi I, Ng YS et al (2010) Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 115:5026-5036
17. Castigli E, Wilson SA et al (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37:829-834 (Pubitemid 41077108)
18. Salzer U, Chapel HM et al (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37:820-828 (Pubitemid 41077107)
19. Warnatz K, Schlesier M (2008) Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 74:261-271
20. Salzer U, Maul-Pavicic A et al (2004) ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 113:234-240 (Pubitemid 39422601)
21. van Zelm MC, Reisli I et al (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354:1901-1912 (Pubitemid 43872691)
22. Warnatz K, Salzer U et al (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 106:13945-13950
23. Warnatz K, Bossaller L et al (2006) Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 107:3045-3052
24. Conley ME, Broides A et al (2005) Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203:216-234 (Pubitemid 40179703)
25. Winkelstein JA, Marino MC et al (2006) X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85:193-202 (Pubitemid 44107177)
26. Ochs HD, Smith CI (1996) X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 75:287-299 (Pubitemid 27009232)
27. Basile N, Danielian S et al (2009) Clinical and molecular analysis of 49 patients with X-linked agammaglobulinemia from a single center in Argentina. J Clin Immunol 29:123-129
28. de Vries E, Noordzij JG, Kuijpers TW, van Dongen JJ (2001) Flow cytometric immunophenotyping in the diagnosis and follow-up of immunodeficient children. Eur J Pediatr 160:583-591 (Pubitemid 32939426)
29. Jacobs ZD, Guajardo JR, Anderson KM (2008) XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol 30:631-634
30. Futatani T, Miyawaki T et al (1998) Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595-602 (Pubitemid 28053383)
31. Mueller OT, Hitchcock R (2008) Gene symbol: BTK. Disease: agammaglobulinaemia. Hum Genet 124:299-300
32. Bonilla FA, Bernstein IL et al (2005) Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 94:S1-S63 (Pubitemid 40712788)
33. Siminovitch KA, Bakhshi A, Goldman P, Korsmeyer SJ (1985) A uniform deleting element mediates the loss of kappa genes in human B cells. Nature 316:260-262 (Pubitemid 15073692)
34. Borte S, von Dobeln U et al (2012) Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood 119:2552-2555
35. O'Gorman MR (2008) Recent developments related to the laboratory diagnosis of primary immunodeficiency diseases. Curr Opin Pediatr 20:688-697
36. Gennery AR, Cant AJ, Jeggo PA (2000) Immunodeficiency associated with DNA repair defects. Clin Exp Immunol 121:1-7 (Pubitemid 30436007)
37. Moin M, Aghamohammadi A et al (2007) Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol 37:21-28 (Pubitemid 47030790)
38. Paganelli R, Scala E et al (1992) Selective deficiency of CD4+/CD45RA+lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol 12:84-91
39. Carbonari M, Cherchi M et al (1990) Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia. N Engl J Med 322:73-76 (Pubitemid 20023863)
40. Porcedda P, Turinetto V et al (2008) A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia. Cytometry A 73:508-516 (Pubitemid 351812848)
41. Folds JD, Schmitz JL (2003) 24. Clinical and laboratory assessment of immunity. J Allergy Clin Immunol 111:S702-S711 (Pubitemid 36223307)
42. Comans-Bitter WM, de Groot R et al (1997) Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130:388-393 (Pubitemid 27492682)
43. Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W (2001) Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98:1847-1851
44. Yates AB, deShazo RD (2001) Delayed hypersensitivity skin testing. Immunol Allergy Clin North Am 21:383-397 (Pubitemid 32552100)
45. (1997), Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep. 46, 1-10.
46. Routes JM, Grossman WJ et al (2009) Statewide newborn screening for severe T-cell lymphopenia. JAMA 302:2465-2470
47. Chase NM, Verbsky JW, Routes JM (2011) Newborn screening for SCID: three years of experience. Ann N Y Acad Sci 1238:99-105
48. Verbsky J, Thakar M, Routes J (2012) The Wisconsin approach to newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 129:622-627
49. Pilch H, Hohn H et al (2002) Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol 9:257-266 (Pubitemid 34226015)
50. Gorski J, Yassai M et al (1994) Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 152:5109-5119 (Pubitemid 24139107)
51. Hodges E, Krishna MT, Pickard C, Smith JL (2003) Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 56:1-11 (Pubitemid 36132467)
52. Geha RS, Notarangelo LD et al (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120:776-794
53. Cooper, M. D., Lanier, L. L., Conley, M. E. and Puck, J.M. (2003), Immunodeficiency disorders. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. 314-330.
54. Noguchi M, Yi H et al (1993) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157 (Pubitemid 23115456)
55. Recher M, Berglund LJ et al (2011) IL-21 is the primary common gamma chain-binding cytokine required for human B-cell differentiation in vivo. Blood 118:6824-6835
56. Fischer A (2000) Severe combined immunodeficiencies (SCID). Clin Exp Immunol 122:143-149
57. Gaspar HB, Gilmour KC, Jones AM (2001) Severe combined immunodeficiency-molecular pathogenesis and diagnosis. Arch Dis Child 84:169-173 (Pubitemid 32150338)
58. Otsu M, Hershfield MS et al (2002) Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy. Hum Gene Ther 13:425-432 (Pubitemid 34251507)
59. Scheimberg I, Hoeger PH, Harper JI, Lake B, Malone M (2001) Omenn's syndrome: differential diagnosis in infants with erythroderma and immunodeficiency. Pediatr Dev Pathol 4:237-245 (Pubitemid 32423822)
60. Gennery AR, Cant AJ (2001) Diagnosis of severe combined immunodeficiency. J Clin Pathol 54:191-195 (Pubitemid 32205038)
61. Reith W, Mach B (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19:331-373 (Pubitemid 32368039)
62. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ (1990) Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). J Pediatr 116:262-265 (Pubitemid 20056783)
63. Nicholson JK (1989) Use of flow cytometry in the evaluation and diagnosis of primary and secondary immunodeficiency diseases. Arch Pathol Lab Med 113:598-605
64. Stewart DM, Candotti F, Nelson DL (2007) The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol 27:634-639
65. Baker MW, Laessig RH et al (2010) Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program. Public Health Rep 125(Suppl 2):88-95
66. Stachon AC, Baskin B et al (2007) Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet A 143A:2924-2930 (Pubitemid 350274806)
67. Tomita-Mitchell A, Mahnke DK et al (2010) Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease. Physiol Genomics 42A:52-60
68. Uygungil B, Bonilla F, Lederman H (2012) Evaluation of a patient with hyper-IgM syndrome. J Allergy Clin Immunol 129(1692-1693):e1694
69. Vargas-Hernandez A, Berron-Ruiz L et al (2012) Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome. Clin Genet 83:585-87
70. O'Gorman MR, Zaas D, Paniagua M, Corrochano V, Scholl PR, Pachman LM (1997) Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers. Clin Immunol Immunopathol 85:172-181 (Pubitemid 27512960)
71. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD (2005) Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105:1881-1890 (Pubitemid 40731768)
72. Seyama K, Nonoyama S et al (1998) Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421-2434 (Pubitemid 28452985)
73. Oliveira JB, Notarangelo LD, Fleisher TA (2008) Applications of flow cytometry for the study of primary immune deficiencies. Curr Opin Allergy Clin Immunol 8:499-509
74. Durandy A, Taubenheim N, Peron S, Fischer A (2007) Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv Immunol 94:275-306 (Pubitemid 46856614)
75. Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92:3007-3017 (Pubitemid 28492304)
76. Mauch L, Lun A et al (2007) Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 53:890-896 (Pubitemid 46744245)
77. Ardati KO, Bajakian KM, Tabbara KS (1997) Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function. Acta Haematol 97:211-215 (Pubitemid 27173966)
78. Grimbacher B, Holland SM et al (1999) Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N Engl J Med 340:692-702 (Pubitemid 29110753)
79. Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129:294-305, quiz 306-297
80. Freeman AF, Holland SM (2010) Clinical manifestations of hyper IgE syndromes. Dis Markers 29:123-130
81. Ochs HD, Oukka M, Torgerson TR (2009) TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 123:977-983, quiz 984-975
82. Orange JS, Ballas ZK (2006) Natural killer cells in human health and disease. Clin Immunol 118:1-10 (Pubitemid 43012040)
83. Bradley TP, Bonavida B (1982) Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay. J Immunol 129:2260-2265 (Pubitemid 12004406)
84. Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294:15-22 (Pubitemid 39626587)
85. Ferlazzo G (2008) Isolation and analysis of human natural killer cell subsets. Methods Mol Biol 415:197-213
86. Hersperger AR, Makedonas G, Betts MR (2008) Flow cytometric detection of perforin upregulation in human CD8 Tcells. Cytometry A 73:1050-1057
87. Clement MV, Haddad P et al (1990) Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Res Immunol 141:477-489 (Pubitemid 20377033)
88. Marcenaro S, Gallo F et al (2006) Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 108:2316-2323 (Pubitemid 44497515)
89. Bryceson YT, Pende D et al (2012) A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 119:2754-2763
90. Zorrilla EP, Luborsky L et al (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15:199-226 (Pubitemid 33070955)
91. Nichols KE, Ma CS, Cannons JL, Schwartzberg PL, Tangye SG (2005) Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 203:180-199 (Pubitemid 40179702)
92. Pachlopnik Schmid J, Canioni D et al (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 117:1522-1529
93. Marsh RA, Villanueva J et al (2009) Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol 132:116-123
94. Marsh RA, Bleesing JJ, Filipovich AH (2010) Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J Immunol Methods 362: 1-9
95. Filipe-Santos O, Bustamante J et al (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18:347-361 (Pubitemid 44540199)
96. Oliveira JB, Fleisher TA (2010) Molecular- and flow cytometry-based diagnosis of primary immunodeficiency disorders. Curr Allergy Asthma Rep 10:460-467
97. Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM (1999) Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 90:425-430 (Pubitemid 29159629)
98. Uzel G, Frucht DM, Fleisher TA, Holland SM (2001) Detection of intracellular phosphorylated STAT-4 by flow cytometry. Clin Immunol 100:270-276
99. Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585-593, quiz 594
100. Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD (2008) Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 28(Suppl 1):S11-S19
101. Nieves DS, Phipps RP et al (2004) Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy. X-linked syndrome. Arch Dermatol 140:466-472 (Pubitemid 38469251)
102. Myers AK, Perroni L, Costigan C, Reardon W (2006) Clinical and molecular findings in IPEX syndrome. Arch Dis Child 91:63-64 (Pubitemid 43059178)
103. Gambineri E, Torgerson TR, Ochs HD (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15:430-435 (Pubitemid 36774255)
104. D'Hennezel E, Ben-Shoshan M et al (2009) FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 361:1710-1713
105. Torgerson TR, Ochs HD (2007) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 120:744-750, quiz 751-742
106. Ochs HD, Ziegler SF, Torgerson TR (2005) FOXP3 acts as a rheostat of the immune response. Immunol Rev 203:156-164 (Pubitemid 40179700)
107. Torgerson TR, Linane A et al (2007) Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology 132:1705-1717 (Pubitemid 46695720)
108. Gavin MA, Torgerson TR et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103: 6659-6664
109. Caudy AA, Reddy ST, Chatila T, Atkinson JP, Verbsky JW (2007) CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119:482-487 (Pubitemid 46204802)
110. Bernasconi A, Marino R et al (2006) Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118:e1584-e1592
111. Rieux-Laucat F, Fischer A, Deist FL (2003) Cell-death signaling and human disease. Curr Opin Immunol 15:325-331 (Pubitemid 36645110)
112. Straus SE, Jaffe ES et al (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194-200
113. Oliveira JB, Bleesing JJ et al (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116:e35-e40
114. Bleesing JJ, Brown MR et al (2001) TcR-alpha/beta(+)CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol 100:314-324
115. Bleesing JJ, Brown MR et al (2001) Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 98:2466-2473